08/15/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2025
5:41 AM | ADMA Biologics (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
08/06/2025
4:15 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2025
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2025
10:22 AM | ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
07/28/2025
8:00 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
8:02 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2025
8:01 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
8:02 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ADMA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ADMA Biologics and its competitors with MarketBeat's FREE daily newsletter. |
06/16/2025
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
7:33 PM | ADMA Biologics (Subject)
ELMS STEVE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
8:00 PM | ADMA Biologics (Issuer)
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
8:00 PM | ADMA Biologics (Subject)
Grossman Jerrold B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2025
4:25 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
12:52 PM | ADMA Biologics (Subject)
Guiheen Lawrence P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2025
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
8:36 PM | ADMA Biologics (Subject)
Guiheen Lawrence P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
9:22 AM | ADMA Biologics (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
05/07/2025
4:15 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
9:29 AM | ADMA Biologics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/28/2025
6:06 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
3:40 PM | ADMA Biologics (Filer)
| Form ARS | |
04/15/2025
3:30 PM | ADMA Biologics (Filer)
| Form DEF 14A | |
04/15/2025
3:35 PM | ADMA Biologics (Filer)
| Form DEFA14A | |
04/02/2025
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
8:40 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
8:00 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:05 PM | ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:05 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:05 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:05 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad) The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million.
Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant. See his full breakdown of the seven stocks to own now |
02/21/2025
8:05 PM | ADMA Biologics (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:05 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:01 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:01 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
8:01 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:25 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
12:51 PM | ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:05 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:10 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:15 PM | ADMA Biologics (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:06 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
6:05 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
8:02 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:00 PM | ADMA Biologics (Subject)
Tade Brad L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
8:00 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
8:05 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:05 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
12:34 PM | ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
8:21 AM | ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
| Form SC 13G | |
11/07/2024
4:00 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:00 AM | ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/31/2024
4:25 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
8:22 AM | ADMA Biologics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
10/10/2024
8:29 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:25 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:27 PM | ADMA Biologics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
09/11/2024
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:00 PM | ADMA Biologics (Subject)
Guiheen Lawrence P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
8:00 PM | ADMA Biologics (Subject)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
8:02 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
8:05 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
8:26 PM | ADMA Biologics (Subject)
Grossman Jerrold B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
8:22 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
8:00 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
8:28 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access